(Q35690877)

9 August 2017

1 reference

title

Pharmacokinetics of valproate in pregnancy: mother-foetus-newborn (English)

1 reference

9 August 2017

1 reference

S. I. Johannessen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1502009

2 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1502009

2 October 2022

publication date

1 June 1992

1 reference

9 August 2017

19 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1502009

Pharmaceutisch weekblad. Scientific edition

2 October 2022

published in

1 reference

9 August 2017

14

1 reference

9 August 2017

3A

1 reference

9 August 2017

114-117

1 reference

Lack of hepatic enzyme inducing effect of sodium valproate

9 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01962699

Valproic acid disposition and protein binding in pregnancy

21 January 2018

1 reference

12 December 2020

Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites

1 reference

12 December 2020

Effects of pregnancy on antiepileptic drug utilization

1 reference

12 December 2020

Monotherapy with valproate in primary generalized epilepsies

1 reference

12 December 2020

Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics

1 reference

12 December 2020

Clinical pharmacokinetics of valproic acid--1988.

1 reference

12 December 2020

Problems and management of the pregnant woman with epilepsy

1 reference

12 December 2020

Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid

1 reference

12 December 2020

Valproic acid and spina bifida: a preliminary report--France

1 reference

12 December 2020

Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.

1 reference

12 December 2020

Therapeutic drug monitoring in pregnancy: rationale and current status

1 reference

12 December 2020

The epileptic mother and her child

1 reference

12 December 2020

Protein binding of antiepileptic drugs during pregnancy, labor, and puerperium

1 reference

12 December 2020

Pharmacokinetics of antiepileptic drugs during pregnancy

1 reference

12 December 2020

Valproic Acid and Metabolites: Pharmacological and Toxicological Studies

1 reference

12 December 2020

Valproic acid: in vitro plasma protein binding and interaction with phenytoin

1 reference

12 December 2020

Free and total serum valproate concentrations: their relationship to seizure control, liver enzymes and plasma ammonia in children

1 reference

12 December 2020

Pharmacokinetics of di-n-propylacetate in epileptic patients

1 reference

12 December 2020

Monitoring of free valproic acid levels?

1 reference

12 December 2020

Plasma protein binding of drugs in pregnancy and in neonates

1 reference

12 December 2020

Therapeutic drug monitoring of anticonvulsants. State of the art.

1 reference

12 December 2020

Problems in therapeutic drug monitoring: free drug level monitoring.

1 reference

12 December 2020

Plasma concentrations of unbound valproate and the management of epilepsy

1 reference

12 December 2020

Valproic Acid Binding to Human Serum Albumin and Determination of Free Fraction in the Presence of Anticonvulsants and Free Fatty Acids

1 reference

12 December 2020

Drugs in human milk. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Reduction of steady-state valproate levels by other antiepileptic drugs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01962699

1 reference

9 August 2017

1 reference